Literature DB >> 28004188

Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.

Abd El-Rahman El-Mashad1, Heba El-Mahdy1, Doaa El Amrousy2, Marwa Elgendy1.   

Abstract

In this prospective study, we compared the efficacy and side effects of indomethacin, ibuprofen, and paracetamol in patent ductus arteriosus (PDA) closure in preterm neonates. Three hundred preterm neonates with hemodynamically significant PDA (hs-PDA) admitted at our neonatal intensive care unit were enrolled in the study. They were randomized into three groups. Group I (paracetamol group) received 15 mg/kg/6 h IV paracetamol infusion for 3 days. Group II (ibuprofen group) received 10 mg/kg IV ibuprofen infusion followed by 5 mg/kg/day for 2 days. Group III (indomethacin group) received 0.2 mg/kg/12 h indomethacin IV infusion for three doses. Laboratory investigations such as renal function test, liver function test, complete blood count, and blood gases were conducted in addition to echocardiographic examinations. All investigations were done before and 3 days after treatment. There was no significant difference between all groups regarding efficacy of PDA closure (P = 0.868). There was a significant increase in serum creatinine levels and serum blood urea nitrogen (BUN) in the ibuprofen and indomethacin groups (P < 0.001). There was a significant reduction in platelet count and urine output (UOP) in both ibuprofen and indomethacin groups (P < 0.001). There was a significant increase in bilirubin levels in only the ibuprofen group (P = 0.003). No significant difference of hemoglobin (HB) level or liver enzymes in all groups (P > 0.05). Ventilatory settings improved significantly in patients with successful closure of PDA than those with failed PDA closure (P < 0.001).
CONCLUSION: Paracetamol is as effective as indomethacin and ibuprofen in closure of PDA in preterm neonates and has less side effects mainly on renal function, platelet count, and GIT bleeding. What is Known: • Hemodynamically significant patent ductus arteriosus has many complications for preterm and low birth weight neonates and better to be closed. Many drugs were used for medical closure of PDA e.g. indomethacin, ibuprofen and recently paracetamol. Many studies compare safety and efficacy of paracetamol with either indomethacin or ibuprofen. What is New: • It is the first large study that compares the efficacy and side effects of the three drugs in one study.

Entities:  

Keywords:  Ibuprofen; Indomethacin; PDA closure; Paracetamol; Preterm neonate

Mesh:

Substances:

Year:  2016        PMID: 28004188     DOI: 10.1007/s00431-016-2830-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  32 in total

1.  Cerebral hemodynamic change and intraventricular hemorrhage in very low birth weight infants with patent ductus arteriosus.

Authors:  Wai-Tim Jim; Nan-Chang Chiu; Ming-Ren Chen; Han-Yang Hung; Hsin-An Kao; Chyong-Hsin Hsu; Jui-Hsing Chang
Journal:  Ultrasound Med Biol       Date:  2005-02       Impact factor: 2.998

2.  Oral ibuprofen versus intravenous indomethacin for closure of patent ductus arteriosus in very low birth weight infants.

Authors:  Cheng Han Lee; Hsiao-Neng Chen; Long-Yen Tsao; Chien-Chou Hsiao; Meng-Luen Lee
Journal:  Pediatr Neonatol       Date:  2012-09-29       Impact factor: 2.083

3.  Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation.

Authors:  P T Manyike; E D Kharasch; T F Kalhorn; J T Slattery
Journal:  Clin Pharmacol Ther       Date:  2000-03       Impact factor: 6.875

4.  A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.

Authors:  B Van Overmeire; K Smets; D Lecoutere; H Van de Broek; J Weyler; K Degroote; J P Langhendries
Journal:  N Engl J Med       Date:  2000-09-07       Impact factor: 91.245

5.  Cellular mechanisms of acetaminophen: role of cyclo-oxygenase.

Authors:  Ruth Lucas; Timothy D Warner; Ivana Vojnovic; Jane A Mitchell
Journal:  FASEB J       Date:  2005-02-10       Impact factor: 5.191

6.  Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.

Authors:  Chuan-Zhong Yang; Jiun Lee
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

7.  Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation.

Authors:  J L Stefano; S Abbasi; S A Pearlman; M L Spear; K L Esterly; V K Bhutani
Journal:  Am Rev Respir Dis       Date:  1991-02

8.  Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis.

Authors:  Lleona C L Lee; Angela Tillett; Robert Tulloh; Robert Yates; Wilf Kelsall
Journal:  BMC Pediatr       Date:  2006-05-11       Impact factor: 2.125

9.  Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure.

Authors:  Daniëlla W E Roofthooft; Ingrid M van Beynum; Johan C A de Klerk; Monique van Dijk; John N van den Anker; Irwin K M Reiss; Dick Tibboel; Sinno H P Simons
Journal:  Eur J Pediatr       Date:  2015-04-30       Impact factor: 3.183

10.  Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial.

Authors:  Dan Dang; Dongxuan Wang; Chuan Zhang; Wenli Zhou; Qi Zhou; Hui Wu
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

View more
  36 in total

1.  Genetic variants associated with patent ductus arteriosus in extremely preterm infants.

Authors:  John M Dagle; Kelli K Ryckman; Cassandra N Spracklen; Allison M Momany; C Michael Cotten; Joshua Levy; Grier P Page; Edward F Bell; Waldemar A Carlo; Seetha Shankaran; Ronald N Goldberg; Richard A Ehrenkranz; Jon E Tyson; Barbara J Stoll; Jeffrey C Murray
Journal:  J Perinatol       Date:  2018-12-05       Impact factor: 2.521

2.  Diagnosis and Management of Patent Ductus Arteriosus.

Authors:  Maria Gillam-Krakauer; Jeff Reese
Journal:  Neoreviews       Date:  2018-07

3.  Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.

Authors:  Arne Ohlsson; Prakeshkumar S Shah
Journal:  Cochrane Database Syst Rev       Date:  2020-01-27

4.  Efficacy and Costs of Three Pharmacotherapies for Patent Ductus Arteriosus Closure in Premature Infants.

Authors:  Ramesh Vidavalur
Journal:  Paediatr Drugs       Date:  2022-03-01       Impact factor: 3.022

Review 5.  Different approaches for patent ductus arteriosus in premature infants using acetaminophen.

Authors:  Aimann Surak; Amish Jain; Abbas Hyderi
Journal:  World J Pediatr       Date:  2022-03-06       Impact factor: 2.764

6.  PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age.

Authors:  Ronald I Clyman; Melissa Liebowitz; Joseph Kaempf; Omer Erdeve; Ali Bulbul; Stellan Håkansson; Johanna Lindqvist; Aijaz Farooqi; Anup Katheria; Jason Sauberan; Jaideep Singh; Kelly Nelson; Andrea Wickremasinghe; Lawrence Dong; Denise C Hassinger; Susan W Aucott; Madoka Hayashi; Anne Marie Heuchan; William A Carey; Matthew Derrick; Erika Fernandez; Meera Sankar; Tina Leone; Jorge Perez; Arturo Serize
Journal:  J Pediatr       Date:  2018-10-16       Impact factor: 4.406

7.  Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.

Authors:  Arne Ohlsson; Rajneesh Walia; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2020-02-11

Review 8.  Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift?

Authors:  P Vali; S Lakshminrusimha; A Pelech; M Underwood; F Ing
Journal:  J Perinatol       Date:  2019-09-27       Impact factor: 3.225

9.  Comparison of the effect of continuous and standard intermittent bolus paracetamol infusion on patent ductus arteriosus.

Authors:  Ufuk Cakir; Cuneyt Tayman; Nazmiye Bengu Karacaglar; Esra Beser; Burak Ceran; Handan Unsal
Journal:  Eur J Pediatr       Date:  2020-09-29       Impact factor: 3.183

10.  Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults.

Authors:  Carlos Martín-Saborido; Jesús López-Alcalde; Agustín Ciapponi; Carlos Enrique Sánchez Martín; Elena Garcia Garcia; Gema Escobar Aguilar; Maria Carolina Palermo; Fernando G Baccaro
Journal:  Cochrane Database Syst Rev       Date:  2019-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.